We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+22.57%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$416M
AUM Growth
+$20.8M
Cap. Flow
-$17.1M
Cap. Flow %
-4.12%
Top 10 Hldgs %
20.36%
Holding
141
New
25
Increased
51
Reduced
35
Closed
30

Top Buys

Rank Stock Value
1
LITE icon
Lumentum
LITE
+$6.26M
2
XMTR icon
Xometry
XMTR
+$5.87M
3
ELF icon
e.l.f. Beauty
ELF
+$5.16M
4
RELY icon
Remitly
RELY
+$5.16M
5
GTLS
Chart Industries
GTLS
+$5.02M

Sector Composition

Rank Sector Weight
1 Technology 28.63%
2 Industrials 28.29%
3 Healthcare 18.04%
4 Consumer Discretionary 12.92%
5 Consumer Staples 5.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KVYO icon
26
Klaviyo
KVYO
$5.78B
$5.46M 1.31%
132,465
-23,345
-15% -$891K
TXRH icon
27
Texas Roadhouse
TXRH
$13.7B
$5.44M 1.31%
30,135
+24,440
+429% +$4.6M
ELF icon
28
e.l.f. Beauty
ELF
$5.09B
$5.4M 1.3%
+43,035
New +$5.16M
ZETA icon
29
Zeta Global
ZETA
$6.75B
$5.39M 1.3%
299,865
-19,245
-6% -$486K
TARS icon
30
Tarsus Pharmaceuticals
TARS
$2.67B
$5.37M 1.29%
96,935
+57,090
+143% +$2.59M
MTSI icon
31
MACOM Technology Solutions
MTSI
$20.1B
$5.36M 1.29%
41,290
+24,715
+149% +$3.11M
CRDO icon
32
Credo Technology Group
CRDO
$41.9B
$5.28M 1.27%
+78,570
New +$3.9M
PAR icon
33
PAR Technology
PAR
$727M
$5.22M 1.26%
71,815
+4,220
+6% +$289K
WGS icon
34
GeneDx Holdings
WGS
$2.08B
$5.22M 1.26%
67,900
+31,285
+85% +$2.19M
ULS icon
35
UL Solutions
ULS
$15.9B
$4.67M 1.12%
93,620
+690
+0.7% +$35.8K
CRS icon
36
Carpenter Technology
CRS
$28.3B
$4.52M 1.09%
26,610
-22,705
-46% -$3.89M
GKOS icon
37
Glaukos
GKOS
$10.1B
$4.47M 1.07%
29,790
+8,460
+40% +$1.17M
CFLT
38
DELISTED
Confluent
CFLT
$4.38M 1.05%
+156,690
New +$4.2M
TNDM icon
39
Tandem Diabetes Care
TNDM
$1.34B
$4.27M 1.03%
118,550
+3,625
+3% +$123K
CRNX icon
40
Crinetics Pharmaceuticals
CRNX
$8.91B
$4.23M 1.02%
82,700
-25,875
-24% -$1.45M
EVR icon
41
Evercore
EVR
$12.3B
$4.22M 1.01%
15,220
+6,455
+74% +$1.83M
LGND icon
42
Ligand Pharmaceuticals
LGND
$6.06B
$4.18M 1.01%
39,010
+14,225
+57% +$1.61M
SAIA icon
43
Saia
SAIA
$9.52B
$4.17M 1%
9,160
+3,395
+59% +$1.68M
KNX icon
44
Knight Transportation
KNX
$11.5B
$4.13M 0.99%
77,945
+35,100
+82% +$1.91M
AZEK
45
DELISTED
The AZEK Co
AZEK
$4.06M 0.98%
+85,435
New +$4.08M
DY icon
46
Dycom Industries
DY
$12.3B
$4.04M 0.97%
23,190
+640
+3% +$118K
VSEC icon
47
VSE Corp
VSEC
$6.05B
$3.98M 0.96%
41,800
+2,455
+6% +$259K
NARI
48
DELISTED
Inari Medical, Inc. Common Stock
NARI
$3.97M 0.95%
+77,755
New +$3.82M
AIT icon
49
Applied Industrial Technologies
AIT
$13.2B
$3.95M 0.95%
16,490
+2,465
+18% +$615K
CORT icon
50
Corcept Therapeutics
CORT
$12B
$3.91M 0.94%
77,665
-35,490
-31% -$1.86M

Similar funds

Lisanti Capital Growth's Q4 2024 Portfolio in Review

As of Q4 2024, Lisanti Capital Growth held 141 positions worth $416M, up 5.3% from $395M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Lisanti Capital Growth withdrew a net $17.1M in Q4 2024, closing 30 positions and reducing 35 holdings. Its most notable exit was Meritage Homes, an estimated $6.97M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 25% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Lisanti Capital Growth opened a new position in Lumentum worth $6.74M.

  • Lisanti Capital Growth's largest Q4 2024 buy was Lumentum: 80,275 shares worth $6.74M.
  • Lisanti Capital Growth added most to JBT Marel in Q4 2024, an estimated $4.91M increase.
  • Lisanti Capital Growth's biggest Q4 2024 reduction was FTAI Aviation, cutting an estimated $8.51M.
  • Lisanti Capital Growth fully exited Meritage Homes in Q4 2024, selling an estimated $6.97M.
  • Lisanti Capital Growth's ten largest holdings make up 20% of its $416M portfolio in Q4 2024.
  • Lisanti Capital Growth opened 25 new positions and closed 30 in Q4 2024.
  • Lisanti Capital Growth's portfolio value rose 5.3% quarter-over-quarter to $416M.

Based on Lisanti Capital Growth's 13F filing for Q4 2024, filed 7 Feb 2025.